BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Vorapaxar

Bleeding Risk

  • Do not use ZONTIVITY in patients with a history of stroke, transient ischemic attack (TIA), or intracranial hemorrhage (ICH); or active pathological bleeding [see CONTRAINDICATIONS (4.1, 4.2)].
  • Antiplatelet agents, including ZONTIVITY, increase the risk of bleeding, including ICH and fatal bleeding [see Warnings and Precautions (5.1)].

 


Patient Counseling Information

Medication Guides

Patient Medication Guide

Package Inserts

Vorapaxar

Updated January 2018